Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP599548.RALCcSc5_AojPeTxkZGKZj8UD5i5bdmW82Y-a6G5RSvH0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP599548.RALCcSc5_AojPeTxkZGKZj8UD5i5bdmW82Y-a6G5RSvH0130_assertion type Assertion NP599548.RALCcSc5_AojPeTxkZGKZj8UD5i5bdmW82Y-a6G5RSvH0130_head.
- NP599548.RALCcSc5_AojPeTxkZGKZj8UD5i5bdmW82Y-a6G5RSvH0130_assertion description "[In 129 Japanese patients with PTC, BRAF(T1799A) was detected in 65 cases (50.4%), and the remaining 64 tumor specimens were subjected to mutation analysis of kinase domains of ARAF, CRAF and MET genes, and hotspots of K- and N-RAS genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP599548.RALCcSc5_AojPeTxkZGKZj8UD5i5bdmW82Y-a6G5RSvH0130_provenance.
- NP599548.RALCcSc5_AojPeTxkZGKZj8UD5i5bdmW82Y-a6G5RSvH0130_assertion evidence source_evidence_literature NP599548.RALCcSc5_AojPeTxkZGKZj8UD5i5bdmW82Y-a6G5RSvH0130_provenance.
- NP599548.RALCcSc5_AojPeTxkZGKZj8UD5i5bdmW82Y-a6G5RSvH0130_assertion SIO_000772 16896265 NP599548.RALCcSc5_AojPeTxkZGKZj8UD5i5bdmW82Y-a6G5RSvH0130_provenance.
- NP599548.RALCcSc5_AojPeTxkZGKZj8UD5i5bdmW82Y-a6G5RSvH0130_assertion wasDerivedFrom befree-20140225 NP599548.RALCcSc5_AojPeTxkZGKZj8UD5i5bdmW82Y-a6G5RSvH0130_provenance.
- NP599548.RALCcSc5_AojPeTxkZGKZj8UD5i5bdmW82Y-a6G5RSvH0130_assertion wasGeneratedBy ECO_0000203 NP599548.RALCcSc5_AojPeTxkZGKZj8UD5i5bdmW82Y-a6G5RSvH0130_provenance.